TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vitalis Pharma AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
109,769
|
101,571
|
95,474 |
Financial expenses |
338
|
398
|
502 |
Earnings before taxes |
28,671
|
17,609
|
20,275 |
Total assets |
44,916
|
58,351
|
46,092 |
Current assets |
8,870
|
19,420
|
16,169 |
Current liabilities |
8,045
|
31,804
|
29,503 |
Equity capital |
546
|
2,618
|
361 |
- share capital |
317
|
308
|
286 |
Employees (average) | 4 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
1.2%
|
4.5%
|
0.8% |
Turnover per employee | 27,442 | ||
Profit as a percentage of turnover |
26.1%
|
17.3%
|
21.2% |
Return on assets (ROA) |
64.6%
|
30.9%
|
45.1% |
Current ratio |
110.3%
|
61.1%
|
54.8% |
Return on equity (ROE) |
5251.1%
|
672.6%
|
5616.3% |
Change turnover |
5,051
|
-990
|
45,195 |
Change turnover % |
5%
|
-1%
|
90% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.